Aeon Biopharma, INC Form 4 insider transactions

AEON Biopharma's CEO, Marc Forth, received a grant of 212,466 stock options on March 19, 2024, vesting over four years.

Chad Oh, Chief Medical Officer of AEON Biopharma, was granted stock options for 86,720 shares on March 19, 2024.

Director Jost Fischer acquired 16,260 stock options in AEON Biopharma, Inc. on March 19, 2024.

Director Eric G. Carter reports the acquisition of stock options in AEON Biopharma, Inc.

Alexander Wilson, Executive VP, CLO & Corporate Secretary of AEON Biopharma, Inc., reports the acquisition of stock options.